We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
BHP
BHP
$213B
| $3.63M | 0.01% |
74,264
-4,161
| -5% | -$189K |
|
602
Vanguard Health Care ETF
VHT
$18.2B
| $3.58M | 0.01% |
18,645
+5,828
| +45% | +$1.05M |
|
603
BioMarin Pharmaceuticals
BMRN
$11.5B
| $3.57M | 0.01% |
42,215
+28,487
| +208% | +$2.15M |
|
604
Vanguard High Dividend Yield ETF
VYM
$81.1B
| $3.52M | 0.01% |
37,584
+67
| +0.2% | +$6.08K |
|
605
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.22B
| $3.52M | 0.01% |
47,195
+1,209
| +3% | +$90.1K |
|
606
Public Service Enterprise Group
PEG
$39.8B
| $3.51M | 0.01% |
59,490
-7,920
| -12% | -$480K |
|
607
Extra Space Storage
EXR
$31.2B
| $3.49M | 0.01% |
33,028
-374
| -1% | -$40.8K |
|
608
Monster Beverage
MNST
$91.4B
| $3.47M | 0.01% |
109,174
-2,204
| -2% | -$64.7K |
|
609
Ollie's Bargain Outlet
OLLI
$4.01B
| $3.46M | 0.01% |
52,903
+6,422
| +14% | +$407K |
|
610
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$565M
| $3.44M | 0.01% |
108,111
+13,211
| +14% | +$417K |
|
611
First Trust Rising Dividend Achievers ETF
RDVY
$24.3B
| $3.42M | 0.01% |
95,127
+31
| +0% | +$1.05K |
|
612
Everest Group
EG
$15.2B
| $3.41M | 0.01% |
12,318
+2
| +0% | +$528 |
|
613
Okta
OKTA
$24.1B
| $3.37M | 0.01% |
29,175
+1,014
| +4% | +$117K |
|
614
Bank of Montreal
BMO
$125B
| $3.36M | 0.01% |
43,305
-4,418
| -9% | -$333K |
|
615
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
| $3.35M | 0.01% |
62,555
+43,446
| +227% | +$2.33M |
|
616
AerCap
AER
$23.9B
| $3.31M | 0.01% |
53,887
+882
| +2% | +$51.9K |
|
617
HEICO Corp Class A
HEI.A
$35.4B
| $3.3M | 0.01% |
36,812
+2,753
| +8% | +$262K |
|
618
Schwab US Large-Cap Growth ETF
SCHG
$58.5B
| $3.29M | 0.01% |
282,808
-6,000
| -2% | -$66.1K |
|
619
CarMax
KMX
$8.27B
| $3.27M | 0.01% |
37,319
-14
| -0% | -$1.32K |
|
620
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.24B
| $3.27M | 0.01% |
29,813
+1,491
| +5% | +$162K |
|
621
Newmont
NEM
$98.2B
| $3.25M | 0.01% |
74,859
+1,317
| +2% | +$51.5K |
|
622
Suncor Energy
SU
$77.7B
| $3.25M | 0.01% |
99,166
-10,753
| -10% | -$336K |
|
|
NATI
623
DELISTED
National Instruments Corp
NATI
| $3.21M | 0.01% |
75,936
+2,321
| +3% | +$97.1K |
|
624
Oneok
OKE
$58.7B
| $3.19M | 0.01% |
42,085
-2,937
| -7% | -$210K |
|
625
Gen Digital
GEN
$15.6B
| $3.17M | 0.01% |
124,089
+2,008
| +2% | +$49.1K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.